Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $56.9836 (-0.58%) ($56.5754 - $57.2441) on Mon. May. 18, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.53% (three month average) | RSI | 41 | Latest Price | $56.9836(-0.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) IBB(48%) VYM(48%) IVE(47%) SPY(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.765% in a week (0% probabilities). VIXM(-22%) TLT(-15%) UUP(-8%) IGOV(-4%) GLD(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.765% (StdDev 1.53%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $56.92(0.11%) | 10 Day Moving Average | $56.54(0.78%) | 20 Day Moving Average | $56.46(0.93%) | To recent high | -1.3% | To recent low | 19.1% | Market Cap | $100.535b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |